Rhythm Pharmaceuticals (RYTM) Share-based Compensation (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Share-based Compensation of $8.5 million for Q1 2026, down 56.1% quarter-over-quarter from $19.3 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Share-based Compensation (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Share-based Compensation for 11 consecutive years, with $8.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation changed N/A year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $75.3 million (up 135.86% YoY), while the FY2025 annual figure was $66.8 million, up 29.45% from the prior year.
- Share-based Compensation fell to $8.5 million in Q1 2026 per RYTM's latest filing, from $19.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $28.7 million in Q2 2025 and bottomed at $4.6 million in Q1 2022.
- Historically, Share-based Compensation has averaged $10.5 million across 5 years, with a median of $8.6 million in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation decreased 11.17% — and 2025, when it jumped 177.49%.
- Rhythm Pharmaceuticals' Share-based Compensation stood at $5.3 million in 2022, then soared by 64.06% to $8.7 million in 2023, then increased by 21.7% to $10.6 million in 2024, then surged by 82.51% to $19.3 million in 2025, then tumbled by 56.1% to $8.5 million in 2026.
- Business Quant data shows RYTM's Share-based Compensation at $8.5 million in Q1 2026, $19.3 million in Q4 2025, and $18.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 26.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.06 Mn |
| Jun 30, 2026 | 26.06 Mn |
| Mar 31, 2026 | 8.46 Mn |
| Mar 31, 2026 | 8.46 Mn |
| Dec 31, 2025 | 19.27 Mn |
| Dec 31, 2025 | 19.27 Mn |
| Sep 30, 2025 | 18.81 Mn |
| Sep 30, 2025 | 18.81 Mn |
| Jun 30, 2025 | 28.74 Mn |
| Jun 30, 2025 | 28.74 Mn |
| Dec 31, 2024 | 10.56 Mn |
| Dec 31, 2024 | 10.56 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 10.36 Mn |
| Jun 30, 2024 | 10.36 Mn |
| Mar 31, 2024 | 7.77 Mn |
| Mar 31, 2024 | 7.77 Mn |
| Dec 31, 2023 | 8.67 Mn |
| Dec 31, 2023 | 8.67 Mn |